Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.9 Billion SEK | -5.24% |
| 2022 | 5.7 Billion SEK | -3.71% |
| 2021 | 6.15 Billion SEK | -16.42% |
| 2020 | 7.2 Billion SEK | 51.51% |
| 2019 | 4.54 Billion SEK | 204.06% |
| 2018 | 1.6 Billion SEK | -66.74% |
| 2017 | 4.05 Billion SEK | 33.77% |
| 2016 | 4.18 Billion SEK | 5.73% |
| 2015 | 3.4 Billion SEK | -11.21% |
| 2014 | 3.83 Billion SEK | -7.5% |
| 2013 | 4.14 Billion SEK | -1.4% |
| 2012 | 4.2 Billion SEK | 2.14% |
| 2011 | 4.11 Billion SEK | 5.94% |
| 2010 | 3.88 Billion SEK | 6.35% |
| 2009 | 3.65 Billion SEK | -77.53% |
| 2008 | 16.26 Billion SEK | 401.54% |
| 2007 | 3.24 Billion SEK | 39.91% |
| 2006 | 2.27 Billion SEK | 8.2% |
| 2005 | 2.14 Billion SEK | 5.34% |
| 2004 | 2.03 Billion SEK | 415.11% |
| 2003 | -645.4 Million SEK | -39.09% |
| 2002 | -464 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.39 Billion SEK | 14.07% |
| 2024 Q1 | 1.28 Billion SEK | -44.28% |
| 2024 Q3 | 861 Million SEK | -27.28% |
| 2023 Q2 | 966 Million SEK | -31.05% |
| 2023 Q1 | 1.4 Billion SEK | -19.62% |
| 2023 Q4 | 1.86 Billion SEK | -11.16% |
| 2023 Q3 | 2.09 Billion SEK | 117.08% |
| 2023 FY | - SEK | -5.24% |
| 2022 Q1 | 1.25 Billion SEK | -7.87% |
| 2022 Q4 | 1.74 Billion SEK | 9.48% |
| 2022 FY | - SEK | -3.71% |
| 2022 Q3 | 1.59 Billion SEK | 17.75% |
| 2022 Q2 | 1.35 Billion SEK | 7.9% |
| 2021 Q4 | 1.36 Billion SEK | -11.92% |
| 2021 FY | - SEK | -16.42% |
| 2021 Q3 | 1.54 Billion SEK | -7.88% |
| 2021 Q2 | 1.67 Billion SEK | 5.54% |
| 2021 Q1 | 1.58 Billion SEK | -21.81% |
| 2020 Q4 | 2.03 Billion SEK | -17.34% |
| 2020 Q2 | 1.83 Billion SEK | 73.96% |
| 2020 Q1 | 1.05 Billion SEK | -41.53% |
| 2020 FY | - SEK | 51.51% |
| 2020 Q3 | 2.45 Billion SEK | 33.75% |
| 2019 Q3 | 1.07 Billion SEK | -1.37% |
| 2019 Q4 | 1.8 Billion SEK | 67.38% |
| 2019 Q1 | 892 Million SEK | -45.97% |
| 2019 Q2 | 1.09 Billion SEK | 22.65% |
| 2019 FY | - SEK | 204.06% |
| 2018 Q3 | -1.13 Billion SEK | -234.4% |
| 2018 Q2 | 846 Million SEK | 249.59% |
| 2018 Q1 | 242 Million SEK | 1.68% |
| 2018 FY | - SEK | -66.74% |
| 2018 Q4 | 1.65 Billion SEK | 245.21% |
| 2017 Q3 | 1.36 Billion SEK | -25.23% |
| 2017 FY | - SEK | 33.77% |
| 2017 Q4 | 238 Million SEK | -82.5% |
| 2017 Q1 | 1.4 Billion SEK | 88.43% |
| 2017 Q2 | 1.81 Billion SEK | 29.93% |
| 2016 Q3 | 1.52 Billion SEK | 101.99% |
| 2016 Q4 | 743 Million SEK | -51.28% |
| 2016 FY | - SEK | 5.73% |
| 2016 Q2 | 755 Million SEK | 30.62% |
| 2016 Q1 | 578 Million SEK | -52.23% |
| 2015 FY | - SEK | -11.21% |
| 2015 Q4 | 1.21 Billion SEK | 42.19% |
| 2015 Q3 | 851 Million SEK | 36.82% |
| 2015 Q2 | 622 Million SEK | -13.49% |
| 2015 Q1 | 719 Million SEK | -20.46% |
| 2014 FY | - SEK | -7.5% |
| 2014 Q2 | 777 Million SEK | -42.1% |
| 2014 Q1 | 1.34 Billion SEK | -12.8% |
| 2014 Q4 | 904 Million SEK | 11.47% |
| 2014 Q3 | 811 Million SEK | 4.38% |
| 2013 FY | - SEK | -1.4% |
| 2013 Q4 | 1.53 Billion SEK | 93.58% |
| 2013 Q3 | 795 Million SEK | -14.61% |
| 2013 Q2 | 931 Million SEK | 5.56% |
| 2013 Q1 | 882 Million SEK | -48.69% |
| 2012 Q4 | 1.71 Billion SEK | 87.87% |
| 2012 Q1 | 704 Million SEK | -59.68% |
| 2012 Q2 | 869 Million SEK | 23.44% |
| 2012 FY | - SEK | 2.14% |
| 2012 Q3 | 915 Million SEK | 5.29% |
| 2011 Q4 | 1.74 Billion SEK | 116.89% |
| 2011 FY | - SEK | 5.94% |
| 2011 Q1 | 690 Million SEK | -53.13% |
| 2011 Q2 | 876 Million SEK | 26.96% |
| 2011 Q3 | 805 Million SEK | -8.11% |
| 2010 Q3 | 864 Million SEK | -0.46% |
| 2010 Q2 | 868 Million SEK | 27.09% |
| 2010 Q1 | 683 Million SEK | -54.92% |
| 2010 FY | - SEK | 6.35% |
| 2010 Q4 | 1.47 Billion SEK | 70.37% |
| 2009 Q2 | 709 Million SEK | 27.06% |
| 2009 FY | - SEK | -77.53% |
| 2009 Q1 | 558 Million SEK | 0.0% |
| 2009 Q4 | 1.51 Billion SEK | 73.74% |
| 2009 Q3 | 872 Million SEK | 22.99% |
| 2008 FY | - SEK | 401.54% |
| 2007 FY | - SEK | 39.91% |
| 2006 FY | - SEK | 8.2% |
| 2005 FY | - SEK | 5.34% |
| 2004 FY | - SEK | 415.11% |
| 2003 FY | - SEK | -39.09% |
| 2002 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.56 Million USD | 15023.767% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 507402.405% |
| Össur hf. | 137.38 Million USD | -4198.265% |
| QHSLab, Inc. | -91.29 Thousand USD | 6468284.855% |
| Wellstar International, Inc. | -1.35 Million USD | 435405.687% |
| Össur hf. | 137.38 Million USD | -4198.265% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -58.46 Thousand USD | 10100850.928% |
| Aurora Spine Corporation | -454.37 Thousand USD | 1299678.765% |
| BrainsWay Ltd. | -2.31 Million USD | 255617.092% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 2152930.945% |
| Hamilton Thorne Ltd. | 5.52 Million USD | -106843.155% |
| Vivos Inc. | -2.79 Million USD | 211510.36% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 2987084.739% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 353999.244% |
| Zecotek Photonics Inc. | -3.44 Million USD | 171646.319% |
| Avitar, Inc. | -1.66 Million USD | 354158.603% |
| Nanomix Corporation | -8.13 Million USD | 72645.074% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | -60314.813% |
| Theraclion SA | -2.05 Million USD | 288038.381% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 406738.153% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 343038.117% |
| Lombard Medical, Inc. | -28.06 Million USD | 21138.193% |
| ALR Technologies Inc. | -6.4 Million USD | 92361.084% |
| Stratec SE | 39.91 Million USD | -14694.308% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -5849736.046% |
| Heart Tronics, Inc. | -14.85 Million USD | 39845.904% |
| MicroPort Scientific Corporation | -347.57 Million USD | 1798.898% |
| VMS Rehab Systems, Inc. | -68.55 USD | 8614150355.288% |
| NewCardio, Inc. | -9.37 Million USD | 63057.609% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 188999.552% |
| Ingen Technologies, Inc. | -8639.00 USD | 68352918.613% |
| Odyssey Group International, Inc. | -2.13 Million USD | 276283.144% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 1558534.018% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 835283.797% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 64621.423% |
| IR-Med Inc. | -4.89 Million USD | 120807.277% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 44575.921% |
| Polarean Imaging plc | -11.19 Million USD | 52846.804% |
| United American Healthcare Corporation | -59 Thousand USD | 10008574.576% |
| ECGI Holdings, Inc. | -2.99 Million USD | 197563.109% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 4993377.467% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 938618.682% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 1148876.81% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -1294685.774% |
| Urologix, Inc. | -6.34 Million USD | 93180.076% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 476555.206% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 771020.94% |
| SS Innovations International, Inc. | -20.37 Million USD | 29080.187% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 2650244.961% |
| Smith & Nephew plc | 1 Billion USD | -488.977% |
| NIOX Group Plc | 11.07 Million USD | -53217.803% |
| Fuse Medical, Inc. | 1.83 Million USD | -321642.959% |
| Broncus Holding Corporation | -25.19 Million USD | 23533.643% |
| Brain Scientific Inc. | -7.93 Million USD | 74529.089% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 62979.995% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 32092491.304% |